Happy Holiday Season
Publié le
Happy Holiday Season from the IDDI team Thank you for all your support throughout the year. Wishing you…
Why do so Many Phase III Fail?
Publié le
Randomized controlled trials (RCTs), particularly in phase 3, are the preferred sources of evidence for drug approval and reimbursement decisions….
Generalized Pairwise Comparisons – GPC
Publié le
AN INNOVATIVE STATISTICAL METHOD PAVING THE WAY TO PERSONALIZED MEDICINE The method of Generalized Pairwise Comparisons (GPC) fulfills a recent literature trend…
AN INNOVATIVE STATISTICAL METHODOLOGY
Publié le
Generalized Pairwise Comparisons – GPC Today’s session is focusing on an innovative statistical methodology called Generalized Pairwise Comparisons – or…
IDDI announces RTSM partnership with Clario
Publié le
PRESS RELEASE Clario to deliver industry leading Randomization, Trial Supply and Management SaaS for new partnership with IDDI Use of…
Statistical Programmer
Publié le
IDDI (International Drug Development Institute), founded in 1991, is a highly recognized biostatistical and eClinical data service provider in the…
Lunch & Learn Workshop
Publié le
Lunch and Learn at MassBio – Cambridge, MA Join our speakers to learn on: Evolution of Thinking about Endpoints in…
Risk-Based Fraud Detection: How Centralized Monitoring Can Boost Data Quality
Publié le
This webinar presented the results of a new study that further demonstrated that risk-based monitoring is an efficient tool to…
Happy Holiday Season
Publié le
IDDI partner in the ShareView project
Publié le
The BENEFIT Team is proud to be named partner in the ShareView Project – A European initiative sponsored by Pfizer…